Oscar Health, Inc. (OSCR) experienced a significant intraday surge of 5.07% on Thursday, driven by positive analyst actions.
The stock's upward movement followed several analyst reports that raised price targets for the healthcare company. UBS increased its target price to $20 from $15 while maintaining a Neutral rating. Similarly, Barclays raised its target price to $21 from $18.
These upward revisions in price targets from major financial institutions contributed to increased investor confidence and buying activity during the trading session, resulting in the notable price appreciation for Oscar Health shares.